This is with reference to your letter dated 4th November, 2025. Kindly find our response to the same attached herewith.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt has responded to a BSE surveillance letter dated 4th November 2025 regarding unusual trading volume in the company's shares. The company stated that it regularly disseminates all price-sensitive information within statutory timelines. After reviewing internal records, operations, and developments, Wockhardt confirmed there is no undisclosed information or pending announcement that could explain the volume movement. The response was submitted under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015.
This is a routine regulatory clarification and does not indicate any negative development. The company's confirmation of no hidden negative news may provide some reassurance to investors wondering about the volume spike, though the exchange may continue to monitor the stock.